Treatment of rheumatoid arthritis in the USA: premature use of tumor necrosis factor inhibition and underutilization of concomitant methotrexate
James R O’Dell,1 Stanley B Cohen,2 J Carter Thorne,3 Joel Kremer4 1Department of Rheumatology, Division of Rheumatology and Immunology, University of Nebraska Medical Center and the Omaha VA, Omaha, NE, USA; 2Department of Internal Medicine, Metroplex Clinical Research Center, University o...
Guardado en:
Autores principales: | O’Dell JR, Cohen SB, Thorne JC, Kremer J |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b147cdb749bc44f491f4e1cf469a6d6b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Risk Factors Associated with Methotrexate Intolerance in Rheumatoid Arthritis Patients
por: Almalag H, et al.
Publicado: (2020) -
Methotrexate-Related Liver Cirrhosis in Psoriatic Arthritis: A Case Report and Review of the Literature
por: Maria-Loukia Koutsompina, et al.
Publicado: (2021) -
METHODS - A randomised controlled trial of METhotrexate to treat Hand Osteoarthritis with Synovitis: study protocol for a randomised controlled trial
por: Yuanyuan Wang, et al.
Publicado: (2021) -
Effects of low-dose tacrolimus therapy in combination with methotrexate in patients with methotrexate-refractory rheumatoid arthritis
por: Takeo Isozaki, et al.
Publicado: (2010) -
Recommendations for optimizing methotrexate treatment for patients with rheumatoid arthritis
por: Bello AE, et al.
Publicado: (2017)